Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Supplement Firms Develop Health Care Provider Channel

This article was originally published in The Tan Sheet

Executive Summary

The market for supplements sold by health care providers heats up, with firms offering practitioner-focused labeling, custom brands and products targeted to specific patient needs. As supplement use grows, more practitioners are interested in guiding patients’ choices in vitamins and other nutritionals.

You may also be interested in...



Emerson Offers E-Commerce To Help Health Care Practitioners Continue Selling Supplements

At least one-third of consumers who have bought supplements from health care providers currently are buying the products online, with Amazon.com the most common seller, says Adam Carr, CEO of Emerson Ecologics. One driver for the trend, in addition to consumers generally using e-commerce for more products, is that Amazon shifted to include premium supplement brands, those previously available only through doctors or other health care practitioners.

People In Brief

Herbalife brings on Dentali as botanical sciences VP; NACDS expands Nicholson’s role; Innophos announces interim CFO; George Hamilton new face of Infusion Life Sciences; Aker BioMarine names sales VP; Atteryd to chair Food Supplements Europe.

FDA Details “Quality Agreements” For Marketers, Contract Manufacturers

The “Contract Manufacturing Arrangements for Drugs: Quality Agreements” draft guidance describes how parties involved in contract manufacturing of drugs can employ quality agreements to delineate their responsibilities and ensure drug quality, safety and efficacy.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS105956

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel